Trisubstituted Pyridinylimidazoles as Potent Inhibitors of the Clinically Resistant L858R/T790M/C797S EGFR Mutant: Targeting of Both Hydrophobic Regions and the Phosphate Binding Site

dc.contributor.author	Juchum, Michael
dc.contributor.author	Laufer, Stefan
dc.contributor.author	Günther, Marcel Benjamin
dc.contributor.author	Döring, Eva
dc.date.accessioned	2017-09-21T14:40:30Z
dc.date.available	2017-09-21T14:40:30Z
dc.date.issued	2017
dc.identifier.issn	1520-4804
dc.identifier.uri	http://hdl.handle.net/10900/77932
dc.language.iso	en	de_DE
dc.publisher	Amer Chemical Soc	de_DE
dc.relation.uri	http://dx.doi.org/10.1021/acs.jmedchem.7b00316	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	540	de_DE
dc.title	Trisubstituted Pyridinylimidazoles as Potent Inhibitors of the Clinically Resistant L858R/T790M/C797S EGFR Mutant: Targeting of Both Hydrophobic Regions and the Phosphate Binding Site	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_00193
utue.publikation.seiten	5613-5637	de_DE
utue.personen.roh	Gunther, Marcel
utue.personen.roh	Lategahn, Jonas
utue.personen.roh	Juchum, Michael
utue.personen.roh	Doring, Eva
utue.personen.roh	Keul, Marina
utue.personen.roh	Engel, Julian
utue.personen.roh	Tumbrink, Hannah L.
utue.personen.roh	Rauh, Daniel
utue.personen.roh	Laufer, Stefan
dcterms.isPartOf.ZSTitelID	Journal of Medicinal Chemistry	de_DE
dcterms.isPartOf.ZS-Issue	13	de_DE
dcterms.isPartOf.ZS-Volume	60	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE